UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2459-2502

2016

Link zum Volltext

Verfügbarkeit prüfen

From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC)

Vascular medicine (London, England), 2020-04, Vol.25 (2), p.103-105

Hiatt, William R

2020

Link zum Volltext

Verfügbarkeit prüfen

Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association

Circulation (New York, N.Y.), 2019-01, Vol.139 (4), p.e10-e33

2019

Link zum Volltext

Verfügbarkeit prüfen

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease

Circulation (New York, N.Y.), 2017-01, Vol.135 (3), p.241-250

2017

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of the Limb Manifestations and Exercise Limitations in Peripheral Artery Disease

Circulation research, 2015-04, Vol.116 (9), p.1527-1539

2015

Link zum Volltext

Verfügbarkeit prüfen

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Circulation (New York, N.Y.), 2017-06, Vol.135 (25), p.2534-2555

2017

Link zum Volltext

Verfügbarkeit prüfen

Acute Limb Ischemia in Peripheral Artery Disease: Insights From EUCLID

Circulation (New York, N.Y.), 2019-08, Vol.140 (7), p.556-565

2019

Link zum Volltext

Verfügbarkeit prüfen

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications

Thrombosis and haemostasis, 2016-06, Vol.115 (6), p.1240

2016

Link zum Volltext

Verfügbarkeit prüfen

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Journal of endovascular therapy, 2015-10, Vol.22 (5), p.663-677

2015

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety

Circulation (New York, N.Y.), 2020-12, Vol.142 (23), p.2219-2230

2020

Link zum Volltext

Verfügbarkeit prüfen

The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease

Circulation (New York, N.Y.), 2014-07, Vol.130 (1), p.69-78

2014

Link zum Volltext

Verfügbarkeit prüfen

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Vascular medicine (London, England), 2015-10, Vol.20 (5), p.465-478

2015

Link zum Volltext

Verfügbarkeit prüfen

Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease

Circulation (New York, N.Y.), 2017-08, Vol.136 (9), p.785-786

2017

Link zum Volltext

Verfügbarkeit prüfen

Omega-3 fatty acids for intermittent claudication

Cochrane database of systematic reviews, 2013-07 (7), p.CD003833-CD003833

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

Circulation (New York, N.Y.), 2021-10, Vol.144 (14), p.1104-1116

2021

Link zum Volltext

Verfügbarkeit prüfen

Response by Brass and Hiatt to Letter Regarding Article, “Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease”

Circulation (New York, N.Y.), 2018-03, Vol.137 (12), p.1304-1304

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)

Journal of vascular surgery, 2008-02, Vol.47 (2), p.330-336.e2

2008

Link zum Volltext

Verfügbarkeit prüfen

Response by Hess and Hiatt to Letter Regarding Article, "A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative"

Circulation (New York, N.Y.), 2017-12, Vol.136 (25), p.2524-2525

2017

Link zum Volltext

Verfügbarkeit prüfen

Lost in translation: Why ‘lost to follow-up’ matters

Vascular medicine (London, England), 2019-08, Vol.24 (4), p.339-340

2019

Link zum Volltext

Verfügbarkeit prüfen

Community walking programs for treatment of peripheral artery disease

Journal of vascular surgery, 2013-12, Vol.58 (6), p.1678-1687

2013

Link zum Volltext

Verfügbarkeit prüfen

Finding Efficacy in a Safety Trial: Empagliflozin and Cardiovascular Death

Circulation (New York, N.Y.), 2016-09, Vol.134 (10), p.773-775

2016

Link zum Volltext

Verfügbarkeit prüfen

Stroke in Patients With Peripheral Artery Disease: Insights From the EUCLID Study

Stroke (1970), 2019-06, Vol.50 (6), p.1356-1363

2019

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

Circulation (New York, N.Y.), 2003-09, Vol.108 (12), p.1481-1486

2003

Link zum Volltext

Verfügbarkeit prüfen

Association between physical activity and peripheral artery disease and carotid artery stenosis in a self-referred population of 3 million adults

Arteriosclerosis, thrombosis, and vascular biology, 2015-01, Vol.35 (1), p.206

2015

Link zum Volltext

Verfügbarkeit prüfen

Assessment of functional status and quality of life in claudication

Journal of vascular surgery, 2011-05, Vol.53 (5), p.1410-1421

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 95

Suche als RSS-Feed

Aktive Filter

ThemaBlood And Lymphatic Vessels

ThemaPeripheral Vascular Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(95)

Sprache

Englisch
(95)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(95)
Science & Technology
(95)
Cardiovascular System & Cardiology
(94)
Humans
(75)
Male
(39)
Female
(36)
Cardiac & Cardiovascular Systems
(33)
Middle Aged
(33)
Aged
(32)
Treatment Outcome
(32)
Surgery
(28)
Peripheral Artery Disease
(25)
Risk Factors
(24)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Aged, 80 And Over
(13)
Peripheral Arterial Disease - Diagnosis
(13)
Intermittent Claudication - Drug Therapy
(12)
Peripheral Arterial Disease - Drug Therapy
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC)

Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease

Pathogenesis of the Limb Manifestations and Exercise Limitations in Peripheral Artery Disease

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Acute Limb Ischemia in Peripheral Artery Disease: Insights From EUCLID

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety

The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease

Omega-3 fatty acids for intermittent claudication

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

Response by Brass and Hiatt to Letter Regarding Article, “Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease”

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)

Response by Hess and Hiatt to Letter Regarding Article, "A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative"

Lost in translation: Why ‘lost to follow-up’ matters

Community walking programs for treatment of peripheral artery disease

Finding Efficacy in a Safety Trial: Empagliflozin and Cardiovascular Death

Stroke in Patients With Peripheral Artery Disease: Insights From the EUCLID Study

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

Association between physical activity and peripheral artery disease and carotid artery stenosis in a self-referred population of 3 million adults

Assessment of functional status and quality of life in claudication

Aktive Filter

Suchergebnisse filtern